GenoChemia Biotechnologies

What GenoChemia Biotechnologies does

GenoChemia Biotechnologies is, by naming convention, a biotechnology company. The compound name "GenoChemia" juxtaposes a genomics/genetics root with "Chemia" (chemistry), and the legal-style "Biotechnologies" suffix suggests an entity operating at the intersection of genetic science and chemistry — plausibly a specialty reagents, services, or research-tools vendor in the life-sciences supply chain, though none of this is confirmed.

No substantive company information could be extracted from the primary corporate source. The company's own website (genochemia.com) returned only a loading/verification page rendering "One moment, please… Please wait while your request is being verified…" and contained no product descriptions, no team information, no pricing, no customer references, no press releases, and no company-history narrative. Every structured extraction field — legal name, founded year, company type, ownership, subsidiaries, funding rounds, management team, office locations, products and services, technology stack, partnerships, regulatory actions, and customer segments — was either empty or explicitly marked as not determinable from source.

The investment-relevant implication is that this company is, from an evidentiary standpoint, effectively a black box. Any diligence assumption about its operating status, product offering, revenue base, or growth direction must be flagged as unsupported. The minimal signal set consists of: (1) the company name implying a biotech orientation, and (2) the existence of a registered domain (genochemia.com). Neither constitutes commercial evidence.

Name

GenoChemia Biotechnologies

Website

https://genochemia.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

GenoChemia Biotechnologies is a biotechnology company whose name implies work at the intersection of genomics and chemistry. No verified information on its specific products, services, customers, technology, leadership, or operational footprint could be extracted from available sources.

Ownership category

akta.pro rank

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation) (HLAAAIAI)

akta.pro secondary industry

Molecular Cytogenetics & Genomic Variation Services (Karyotyping/FISH/aCGH/CNV) (HLAGANAJ)

Keywords

• Biotechnology supply
• Molecular biology reagents
• Genomics research tools
• Life science consumables
• Biochemical products

Headquarters

HQ city

Chicoutimi

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Core offering

Source content provided no substantive information about GenoChemia Biotechnologies' products or services. The only accessible page was a Cloudflare-style loading/verification screen ("One moment, please...").

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Thermo Fisher Scientific: Largest life-sciences tools and services company spanning reagents, instruments, and contract research. Comparable as a broad incumbent whose portfolio overlaps with any chemistry-plus-genomics specialist.
• Charles River Laboratories: Global CRO offering discovery, safety assessment, and manufacturing services across biology and chemistry. Comparable as an established services provider at the biology-chemistry interface that a GenoChemia-style specialist might partner with or compete against.
• Illumina: Dominant provider of DNA sequencing instruments, reagents, and genomics services. Comparable as the broad incumbent defining the genomics category in which a GenoChemia-branded company would operate.
• Eurofins Scientific: Global leader in bioanalytical testing and genomics services across pharma, food, and clinical end markets. Comparable as a broad life-sciences services incumbent with strong chemistry/genomics capabilities.

Direct peers

• Integrated DNA Technologies (IDT): Major supplier of custom oligonucleotides, genes, and genomics reagents. Comparable as a chemistry-driven genomics products/services company serving similar research and diagnostics end markets.
• Twist Bioscience: Provider of synthetic DNA, gene fragments, and DNA data storage. Highly comparable given the 'GenoChemia' brand positioning around DNA/chemistry products sold to research and biopharma customers.
• GenScript: Global biotech services company offering gene synthesis, protein engineering, and cell therapy services. Comparable to GenoChemia as a services-oriented provider operating at the biology-chemistry interface for research customers.
• NeoGenomics: Specialized oncology-focused clinical genomics and pathology testing company. Comparable as a smaller-scale, niche-focused genetics/chemistry services provider serving clinical customers.
• Bio-Techne: Developer and manufacturer of high-quality reagents, assays, and proteins for life science research and diagnostics. Comparable due to the biotech-reagents positioning implied by the GenoChemia brand.
• Pacific Biosciences: Developer of long-read DNA sequencing platforms and genomics tools. Comparable as a genomics-specialist serving research and clinical customers.

Market position

Strengths1 record

Weaknesses1 record

Key risks1 record

Key highlights2 records

Customer concentration

• Facebookfacebook.com/GenoChemiaBiotech
• LinkedInlinkedin.com/company/genochemia-biotecnologies

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenoChemia Biotechnologies